| 000 | 01852 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516041710.0 | ||
| 264 | 0 | _c20120612 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdr263 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPierga, J-Y | |
| 245 | 0 | 0 |
_aHigh independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMar 2012 |
||
| 300 |
_a618-624 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBreast Neoplasms _xblood |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplastic Cells, Circulating _xdrug effects |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 700 | 1 | _aHajage, D | |
| 700 | 1 | _aBachelot, T | |
| 700 | 1 | _aDelaloge, S | |
| 700 | 1 | _aBrain, E | |
| 700 | 1 | _aCampone, M | |
| 700 | 1 | _aDiéras, V | |
| 700 | 1 | _aRolland, E | |
| 700 | 1 | _aMignot, L | |
| 700 | 1 | _aMathiot, C | |
| 700 | 1 | _aBidard, F-C | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 23 _gno. 3 _gp. 618-624 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdr263 _zAvailable from publisher's website |
| 999 |
_c20900819 _d20900819 |
||